Microbiota and human allergic diseases: the company we keep
Environmental, maternal and early life microbial/immune networks program human developmental trajectories and health outcomes and strongly modify allergic disease risk. The effects of environmental microbiota are illustrated by the ‘farm effect’ (the protection against asthma and allergy conferred b...
Gespeichert in:
Veröffentlicht in: | Current opinion in immunology 2021-10, Vol.72, p.215-220 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 220 |
---|---|
container_issue | |
container_start_page | 215 |
container_title | Current opinion in immunology |
container_volume | 72 |
creator | Vercelli, Donata |
description | Environmental, maternal and early life microbial/immune networks program human developmental trajectories and health outcomes and strongly modify allergic disease risk. The effects of environmental microbiota are illustrated by the ‘farm effect’ (the protection against asthma and allergy conferred by growing up on a traditional farm) and other natural experiments in populations exposed to microbe-rich environments. The role of gut microbiome maturation in the asthma/allergy trajectory is demonstrated by the most recent farm studies, which identified microbial metabolites specifically associated with asthma protection, and studies in other cohorts, which defined dynamic microbial community profiles associated with allergic disease phenotypes. Current and future studies in germ-free mice associated with gut microbiota from human disease states are providing novel mechanistic insights into the role of microbiota in shaping immune function and allergic disease susceptibility. |
doi_str_mv | 10.1016/j.coi.2021.06.002 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8578191</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0952791521000704</els_id><sourcerecordid>2546601606</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-a3d7d657612efa599ec3f902dab9aa01b1bb7589c5525369b2462f3f7806ac0f3</originalsourceid><addsrcrecordid>eNp1kE1P3DAQhi1UBFvgB_RS5dhL0rGztuMiVUKrFpBAXOBsTZwJ620-tnZCxb_Hq6WoPXCaw7zvM6OHsU8cCg5cfd0UbvSFAMELUAWAOGALXmmTQ6nFB7YAI0WuDZfH7GOMGwCQsoQjdlwueSWE5gt2futdGGs_Tpjh0GTrucchw66j8Ohd1vhIGCl-y6Y1ZW7stzg8Z38o-0W0PWWHLXaRzl7nCXv4-eN-dZXf3F1ery5ucreUfMqxbHSjpFZcUIvSGHJla0A0WBtE4DWvay0r46QUslSmFksl2rLVFSh00JYn7Pueu53rnhpHwxSws9vgewzPdkRv_98Mfm0fxydbSV1xwxPgyysgjL9nipPtfXTUdTjQOEcr5FKpJBRUivJ9NFmJMVD7doaD3Um3G5uk2510C8om6anz-d__3hp_LafA-T5AydKTp2Cj8zQ4anwgN9kmAd_HvwBdNpJk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2546601606</pqid></control><display><type>article</type><title>Microbiota and human allergic diseases: the company we keep</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Vercelli, Donata</creator><creatorcontrib>Vercelli, Donata</creatorcontrib><description>Environmental, maternal and early life microbial/immune networks program human developmental trajectories and health outcomes and strongly modify allergic disease risk. The effects of environmental microbiota are illustrated by the ‘farm effect’ (the protection against asthma and allergy conferred by growing up on a traditional farm) and other natural experiments in populations exposed to microbe-rich environments. The role of gut microbiome maturation in the asthma/allergy trajectory is demonstrated by the most recent farm studies, which identified microbial metabolites specifically associated with asthma protection, and studies in other cohorts, which defined dynamic microbial community profiles associated with allergic disease phenotypes. Current and future studies in germ-free mice associated with gut microbiota from human disease states are providing novel mechanistic insights into the role of microbiota in shaping immune function and allergic disease susceptibility.</description><identifier>ISSN: 0952-7915</identifier><identifier>EISSN: 1879-0372</identifier><identifier>DOI: 10.1016/j.coi.2021.06.002</identifier><identifier>PMID: 34182271</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Age Factors ; Disease Susceptibility ; Environmental Exposure ; Host Microbial Interactions - immunology ; Humans ; Hypersensitivity - diagnosis ; Hypersensitivity - etiology ; Hypersensitivity - metabolism ; Microbiota - immunology</subject><ispartof>Current opinion in immunology, 2021-10, Vol.72, p.215-220</ispartof><rights>2021 Elsevier Ltd</rights><rights>Copyright © 2021 Elsevier Ltd. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-a3d7d657612efa599ec3f902dab9aa01b1bb7589c5525369b2462f3f7806ac0f3</citedby><cites>FETCH-LOGICAL-c451t-a3d7d657612efa599ec3f902dab9aa01b1bb7589c5525369b2462f3f7806ac0f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.coi.2021.06.002$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>230,314,780,784,885,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34182271$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vercelli, Donata</creatorcontrib><title>Microbiota and human allergic diseases: the company we keep</title><title>Current opinion in immunology</title><addtitle>Curr Opin Immunol</addtitle><description>Environmental, maternal and early life microbial/immune networks program human developmental trajectories and health outcomes and strongly modify allergic disease risk. The effects of environmental microbiota are illustrated by the ‘farm effect’ (the protection against asthma and allergy conferred by growing up on a traditional farm) and other natural experiments in populations exposed to microbe-rich environments. The role of gut microbiome maturation in the asthma/allergy trajectory is demonstrated by the most recent farm studies, which identified microbial metabolites specifically associated with asthma protection, and studies in other cohorts, which defined dynamic microbial community profiles associated with allergic disease phenotypes. Current and future studies in germ-free mice associated with gut microbiota from human disease states are providing novel mechanistic insights into the role of microbiota in shaping immune function and allergic disease susceptibility.</description><subject>Age Factors</subject><subject>Disease Susceptibility</subject><subject>Environmental Exposure</subject><subject>Host Microbial Interactions - immunology</subject><subject>Humans</subject><subject>Hypersensitivity - diagnosis</subject><subject>Hypersensitivity - etiology</subject><subject>Hypersensitivity - metabolism</subject><subject>Microbiota - immunology</subject><issn>0952-7915</issn><issn>1879-0372</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp1kE1P3DAQhi1UBFvgB_RS5dhL0rGztuMiVUKrFpBAXOBsTZwJ620-tnZCxb_Hq6WoPXCaw7zvM6OHsU8cCg5cfd0UbvSFAMELUAWAOGALXmmTQ6nFB7YAI0WuDZfH7GOMGwCQsoQjdlwueSWE5gt2futdGGs_Tpjh0GTrucchw66j8Ohd1vhIGCl-y6Y1ZW7stzg8Z38o-0W0PWWHLXaRzl7nCXv4-eN-dZXf3F1ery5ucreUfMqxbHSjpFZcUIvSGHJla0A0WBtE4DWvay0r46QUslSmFksl2rLVFSh00JYn7Pueu53rnhpHwxSws9vgewzPdkRv_98Mfm0fxydbSV1xwxPgyysgjL9nipPtfXTUdTjQOEcr5FKpJBRUivJ9NFmJMVD7doaD3Um3G5uk2510C8om6anz-d__3hp_LafA-T5AydKTp2Cj8zQ4anwgN9kmAd_HvwBdNpJk</recordid><startdate>20211001</startdate><enddate>20211001</enddate><creator>Vercelli, Donata</creator><general>Elsevier Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211001</creationdate><title>Microbiota and human allergic diseases: the company we keep</title><author>Vercelli, Donata</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-a3d7d657612efa599ec3f902dab9aa01b1bb7589c5525369b2462f3f7806ac0f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Age Factors</topic><topic>Disease Susceptibility</topic><topic>Environmental Exposure</topic><topic>Host Microbial Interactions - immunology</topic><topic>Humans</topic><topic>Hypersensitivity - diagnosis</topic><topic>Hypersensitivity - etiology</topic><topic>Hypersensitivity - metabolism</topic><topic>Microbiota - immunology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vercelli, Donata</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Current opinion in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vercelli, Donata</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Microbiota and human allergic diseases: the company we keep</atitle><jtitle>Current opinion in immunology</jtitle><addtitle>Curr Opin Immunol</addtitle><date>2021-10-01</date><risdate>2021</risdate><volume>72</volume><spage>215</spage><epage>220</epage><pages>215-220</pages><issn>0952-7915</issn><eissn>1879-0372</eissn><abstract>Environmental, maternal and early life microbial/immune networks program human developmental trajectories and health outcomes and strongly modify allergic disease risk. The effects of environmental microbiota are illustrated by the ‘farm effect’ (the protection against asthma and allergy conferred by growing up on a traditional farm) and other natural experiments in populations exposed to microbe-rich environments. The role of gut microbiome maturation in the asthma/allergy trajectory is demonstrated by the most recent farm studies, which identified microbial metabolites specifically associated with asthma protection, and studies in other cohorts, which defined dynamic microbial community profiles associated with allergic disease phenotypes. Current and future studies in germ-free mice associated with gut microbiota from human disease states are providing novel mechanistic insights into the role of microbiota in shaping immune function and allergic disease susceptibility.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>34182271</pmid><doi>10.1016/j.coi.2021.06.002</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0952-7915 |
ispartof | Current opinion in immunology, 2021-10, Vol.72, p.215-220 |
issn | 0952-7915 1879-0372 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8578191 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Age Factors Disease Susceptibility Environmental Exposure Host Microbial Interactions - immunology Humans Hypersensitivity - diagnosis Hypersensitivity - etiology Hypersensitivity - metabolism Microbiota - immunology |
title | Microbiota and human allergic diseases: the company we keep |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T06%3A19%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Microbiota%20and%20human%20allergic%20diseases:%20the%20company%20we%20keep&rft.jtitle=Current%20opinion%20in%20immunology&rft.au=Vercelli,%20Donata&rft.date=2021-10-01&rft.volume=72&rft.spage=215&rft.epage=220&rft.pages=215-220&rft.issn=0952-7915&rft.eissn=1879-0372&rft_id=info:doi/10.1016/j.coi.2021.06.002&rft_dat=%3Cproquest_pubme%3E2546601606%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2546601606&rft_id=info:pmid/34182271&rft_els_id=S0952791521000704&rfr_iscdi=true |